BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7010003)

  • 1. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
    Fuster V; Chesebro JH
    Mayo Clin Proc; 1981 Mar; 56(3):185-95. PubMed ID: 7010003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prospects of antiaggregant therapy in prevention of atherosclerosis].
    Strano A; Novo S
    G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163
    [No Abstract]   [Full Text] [Related]  

  • 4. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding associated with antithrombotic therapy.
    Kelton JG; Hirsh J
    Semin Hematol; 1980 Oct; 17(4):259-91. PubMed ID: 6160618
    [No Abstract]   [Full Text] [Related]  

  • 8. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevention of thrombosis.
    Bove LG
    J Maine Med Assoc; 1974 Oct; 65(10):233-5. PubMed ID: 4610070
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic therapy.
    Kazmier FJ
    Cardiovasc Clin; 1983; 13(2):321-33. PubMed ID: 6839327
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-inhibitor drugs' role in coronary artery disease.
    Fuster V; Adams PC; Badimon JJ; Chesebro JH
    Prog Cardiovasc Dis; 1987; 29(5):325-46. PubMed ID: 3547499
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet agents and extracorporeal circulation.
    Weston MJ; Woods HF; Turney JH
    Int J Artif Organs; 1980 May; 3(3):129-32. PubMed ID: 7000714
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.
    Domoto DT; Bauman JE; Joist JH
    Thromb Res; 1991 Jun; 62(6):737-43. PubMed ID: 1926064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
    Fuster V; Chesebro JH
    Mayo Clin Proc; 1981 Apr; 56(4):265-73 concl. PubMed ID: 7012464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.